| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Nicole J Yang | |
| Marlon J Hinner | |||
| P2860 | cites work | Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases | Q24601963 |
| A class of human proteins that deliver functional proteins into mammalian cells in vitro and in vivo | Q24619754 | ||
| A vector-free microfluidic platform for intracellular delivery | Q24623995 | ||
| Potent delivery of functional proteins into Mammalian cells in vitro and in vivo using a supercharged protein | Q24630131 | ||
| Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21) | Q24633690 | ||
| Direct inhibition of the NOTCH transcription factor complex | Q24634015 | ||
| Ribosome-inactivating proteins: from plant defense to tumor attack | Q26828935 | ||
| Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance | Q26865927 | ||
| How viruses use the endoplasmic reticulum for entry, replication, and assembly | Q26996825 | ||
| Getting in shape: controlling peptide bioactivity and bioavailability using conformational constraints | Q27021652 | ||
| Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers | Q27665492 | ||
| Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy | Q27679680 | ||
| Stabilizing the pro-apoptotic BimBH3 helix (BimSAHB) does not necessarily enhance affinity or biological activity | Q27683432 | ||
| Structural studies of HIV-1 Tat protein | Q27730186 | ||
| Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings | Q27861111 | ||
| Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration | Q77658726 | ||
| Intramolecular hydrogen bonding in medicinal chemistry | Q82995177 | ||
| Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape | Q83294573 | ||
| Use of 3D properties to characterize beyond rule-of-5 property space for passive permeation | Q83582009 | ||
| Synthesis of all-hydrocarbon stapled α-helical peptides by ring-closing olefin metathesis | Q84261511 | ||
| The Proton Sponge: a Trick to Enter Cells the Viruses Did Not Exploit | Q120478778 | ||
| Shiga toxins--from cell biology to biomedical applications | Q37659792 | ||
| Targeting antibodies to the cytoplasm | Q37811739 | ||
| Tailoring nanocarriers for intracellular protein delivery | Q37874945 | ||
| How ricin and Shiga toxin reach the cytosol of target cells: retrotranslocation from the endoplasmic reticulum | Q37901423 | ||
| Viral weapons of membrane destruction: variable modes of membrane penetration by non-enveloped viruses | Q37909045 | ||
| Cholera toxin: an intracellular journey into the cytosol by way of the endoplasmic reticulum | Q37954281 | ||
| First crystal structures of Na+,K+-ATPase: new light on the oldest ion pump. | Q37966251 | ||
| Self assembling nanocomposites for protein delivery: supramolecular interactions of soluble polymers with protein drugs. | Q37972506 | ||
| Synthetic nanocarriers for intracellular protein delivery | Q37980239 | ||
| Evidence-based approach to assess passive diffusion and carrier-mediated drug transport | Q38003002 | ||
| Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approach. | Q38019048 | ||
| Insights on the trafficking and retro-translocation of glycosphingolipid-binding bacterial toxins | Q38037553 | ||
| Homeoproteins and homeoprotein-derived peptides: going in and out. | Q38058880 | ||
| Arginine-rich peptides: methods of translocation through biological membranes | Q38058882 | ||
| Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells. | Q38073082 | ||
| Uncoating of non-enveloped viruses | Q38075203 | ||
| Inhibition of α-helix-mediated protein-protein interactions using designed molecules | Q38082945 | ||
| The urea transporter family (SLC14): physiological, pathological and structural aspects | Q38090776 | ||
| The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29. | Q38090786 | ||
| Transporter biology in drug approval: regulatory aspects | Q38090802 | ||
| Form and function in cyclic peptide natural products: a pharmacokinetic perspective | Q38098254 | ||
| Cell-penetrating peptides: 20 years later, where do we stand? | Q38106559 | ||
| Retrograde transport of protein toxins through the Golgi apparatus | Q38114338 | ||
| P-glycoprotein Inhibition for Optimal Drug Delivery. | Q38136183 | ||
| Sec22b regulates phagosomal maturation and antigen crosspresentation by dendritic cells | Q28119175 | ||
| Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans | Q28140638 | ||
| Molecular background of leak K+ currents: two-pore domain potassium channels | Q28279763 | ||
| Permeability of small nonelectrolytes through lipid bilayer membranes | Q28303833 | ||
| Use of cyclodextrins to monitor transbilayer movement and differential lipid affinities of cholesterol | Q28359664 | ||
| Chemical synthesis of hydrocarbon-stapled peptides for protein interaction research and therapeutic targeting | Q28833483 | ||
| Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties | Q28842810 | ||
| Regulated portals of entry into the cell | Q29547391 | ||
| Virus entry by endocytosis | Q29619724 | ||
| Molecular basis of the structure and function of H1 hemagglutinin of influenza virus. | Q30418463 | ||
| An engineered substance P variant for receptor-mediated delivery of synthetic antibodies into tumor cells | Q30488727 | ||
| Controlled delivery of bioactive molecules into live cells using the bacterial mechanosensitive channel MscL. | Q30539714 | ||
| 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries | Q30854803 | ||
| Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat(47-57) through well-differentiated epithelial models | Q33205440 | ||
| A high-throughput assay for assessing the cell permeability of combinatorial libraries | Q33215569 | ||
| Improved assays for determining the cytosolic access of peptides, proteins, and their mimetics | Q33553611 | ||
| Membrane-bound dynamic structure of an arginine-rich cell-penetrating peptide, the protein transduction domain of HIV TAT, from solid-state NMR. | Q33605186 | ||
| Targeted cytolysins synergistically potentiate cytoplasmic delivery of gelonin immunotoxin. | Q33647683 | ||
| Vertical silicon nanowires as a universal platform for delivering biomolecules into living cells. | Q33719560 | ||
| The effect of multiple N-methylation on intestinal permeability of cyclic hexapeptides | Q33837256 | ||
| Oxygen permeability of phosphatidylcholine--cholesterol membranes | Q33861788 | ||
| The SLC2 (GLUT) family of membrane transporters | Q33926133 | ||
| Penetration of protein toxins into cells | Q33954510 | ||
| Evolution of the physicochemical properties of marketed drugs: can history foretell the future? | Q33969389 | ||
| Immunotoxin treatment of cancer | Q34000417 | ||
| Lipid rafts: at a crossroad between cell biology and physics. | Q34001726 | ||
| On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds | Q34030237 | ||
| Cell-penetrating peptides: breaking through to the other side | Q34032300 | ||
| The transporter classification database | Q34038896 | ||
| Voltage-dependent translocation of R18 and DiI across lipid bilayers leads to fluorescence changes | Q34041090 | ||
| Coexistence of passive and carrier-mediated processes in drug transport | Q34128770 | ||
| Molecular properties that influence the oral bioavailability of drug candidates | Q34130727 | ||
| Influence of chain ordering on the selectivity of dipalmitoylphosphatidylcholine bilayer membranes for permeant size and shape | Q34169488 | ||
| Probing red cell membrane cholesterol movement with cyclodextrin | Q34178911 | ||
| A yeast-based screen reveals that sulfasalazine inhibits tetrahydrobiopterin biosynthesis. | Q34178953 | ||
| On the biomedical promise of cell penetrating peptides: limits versus prospects | Q36925714 | ||
| Engineering the type III secretion system in non-replicating bacterial minicells for antigen delivery | Q36957667 | ||
| Structure and biophysics of type III secretion in bacteria | Q37014297 | ||
| Targeting cancer with a lupus autoantibody | Q37019392 | ||
| Activation, exposure and penetration of virally encoded, membrane-active polypeptides during non-enveloped virus entry | Q37108551 | ||
| The exploration of macrocycles for drug discovery--an underexploited structural class | Q37203934 | ||
| Microinjection as a tool of mechanical delivery | Q37251469 | ||
| Alternative mechanisms for the interaction of the cell-penetrating peptides penetratin and the TAT peptide with lipid bilayers | Q37263388 | ||
| Aquaporin water channels in mammals | Q37351562 | ||
| Arginine-rich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell-penetrating peptides | Q37373439 | ||
| Virus entry by macropinocytosis | Q37464753 | ||
| Membrane translocation by anthrax toxin | Q37535082 | ||
| Modular Cre/lox system and genetic therapeutics for colorectal cancer | Q37609953 | ||
| Arginine-rich cell-penetrating peptides. | Q37635334 | ||
| Permeation across hydrated DPPC lipid bilayers: simulation of the titrable amphiphilic drug valproic acid | Q34183816 | ||
| Cell-penetrating peptides: classes, origin, and current landscape | Q34215571 | ||
| Stapled peptides for intracellular drug targets | Q34245833 | ||
| Amino acid secondary transporters: toward a common transport mechanism | Q34313450 | ||
| The ABCs of membrane transporters in health and disease (SLC series): introduction | Q34333686 | ||
| The mechanism of ammonia transport based on the crystal structure of AmtB of Escherichia coli | Q34371143 | ||
| Cell-penetrating peptides: design, synthesis, and applications | Q34405943 | ||
| Membranes are more mosaic than fluid | Q34471724 | ||
| Molecular characterization and inhibition of amanitin uptake into human hepatocytes | Q34496951 | ||
| The Amt/Mep/Rh family of ammonium transport proteins | Q34665528 | ||
| Membrane traffic exploited by protein toxins | Q34762458 | ||
| Tat-mediated delivery of heterologous proteins into cells | Q34991904 | ||
| Lipid-protein interactions in biological membranes: a structural perspective | Q35120901 | ||
| Protein delivery using engineered virus-like particles | Q35345000 | ||
| Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions | Q35345277 | ||
| Treatment of hematologic malignancies with immunotoxins and antibody-drug conjugates | Q35446333 | ||
| Intracellular trafficking of polyamidoamine-poly(ethylene glycol) block copolymers in DNA delivery | Q35555581 | ||
| Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development | Q35801921 | ||
| An orthosteric inhibitor of the Ras-Sos interaction | Q35854216 | ||
| Packing a punch: the mechanism of pore formation by cholesterol dependent cytolysins and membrane attack complex/perforin-like proteins | Q36059050 | ||
| Solid-phase synthesis of short α-helices stabilized by the hydrogen bond surrogate approach | Q36074865 | ||
| Delivery into cells: lessons learned from plant and bacterial toxins | Q36091291 | ||
| The pathway of US11-dependent degradation of MHC class I heavy chains involves a ubiquitin-conjugated intermediate | Q36310746 | ||
| Reversible α-helix formation controlled by a hydrogen bond surrogate | Q36375486 | ||
| Diffusion of carbon dioxide through lipid bilayer membranes: effects of carbonic anhydrase, bicarbonate, and unstirred layers | Q36408324 | ||
| The nonelectrolyte permeability of planar lipid bilayer membranes | Q36409187 | ||
| Free energy of translocating an arginine-rich cell-penetrating peptide across a lipid bilayer suggests pore formation | Q36554270 | ||
| Liposomal drug transport: a molecular perspective from molecular dynamics simulations in lipid bilayers | Q36648264 | ||
| Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications | Q36700240 | ||
| Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy. | Q36709135 | ||
| In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine | Q36762590 | ||
| Dynamic regulatory network controlling TH17 cell differentiation | Q36799525 | ||
| Penetration of nonenveloped viruses into the cytoplasm | Q36800410 | ||
| Aquaporin-facilitated transmembrane diffusion of hydrogen peroxide. | Q38141474 | ||
| Intracellular delivery of protein and peptide therapeutics | Q38224946 | ||
| The free hormone hypothesis: a physiologically based mathematical model | Q38688486 | ||
| Evaluating the role of substance P in the growth of brain tumors | Q39038904 | ||
| Synergistic antitumor activity from two-stage delivery of targeted toxins and endosome-disrupting nanoparticles | Q39187821 | ||
| Supercharging proteins can impart unusual resilience | Q39273315 | ||
| Substance P derivatives as versatile tools for specific delivery of various types of biomolecular cargo | Q39427146 | ||
| Development of a new permeability assay using low-efflux MDCKII cells. | Q39505199 | ||
| Stapled Vasoactive Intestinal Peptide (VIP) Derivatives Improve VPAC2 Agonism and Glucose-Dependent Insulin Secretion | Q39771664 | ||
| Fluorophores for live cell imaging of AGT fusion proteins across the visible spectrum | Q40240937 | ||
| Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. | Q40591045 | ||
| Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake | Q40692947 | ||
| Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement | Q40841743 | ||
| Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter | Q41070241 | ||
| Arginine topology controls escape of minimally cationic proteins from early endosomes to the cytoplasm | Q41500169 | ||
| Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport | Q41509109 | ||
| Fluorescent cellular indicators are extruded by the multidrug resistance protein. | Q41520976 | ||
| A conserved anti-DNA antibody idiotype associated with nephritis in murine and human systemic lupus erythematosus. | Q41898082 | ||
| Water and nonelectrolyte permeability of lipid bilayer membranes | Q41933125 | ||
| The possible "proton sponge " effect of polyethylenimine (PEI) does not include change in lysosomal pH. | Q42541130 | ||
| Independence of substituent contributions to the transport of small molecule permeants in lipid bilayers | Q42564712 | ||
| Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach | Q42581818 | ||
| Distinct BimBH3 (BimSAHB) stapled peptides for structural and cellular studies. | Q42788323 | ||
| A peptide carrier for the delivery of biologically active proteins into mammalian cells. | Q42823248 | ||
| N-methyl phenylalanine-rich peptides as highly versatile blood-brain barrier shuttles | Q43156566 | ||
| Molecular view of cholesterol flip-flop and chemical potential in different membrane environments. | Q43293237 | ||
| A novel intracellular protein delivery platform based on single-protein nanocapsules | Q44697222 | ||
| Intracellular delivery of proteins with a new lipid-mediated delivery system | Q45878581 | ||
| Endoprotease-mediated intracellular protein delivery using nanocapsules. | Q45932573 | ||
| Protein nanocapsule weaved with enzymatically degradable polymeric network | Q46183480 | ||
| Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides | Q46328799 | ||
| Flip-flop is slow and rate limiting for the movement of long chain anthroyloxy fatty acids across lipid vesicles | Q46485116 | ||
| Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis. | Q51800763 | ||
| The transport of steroids into animal cells in culture. | Q52741206 | ||
| Interpretation of nonelectrolyte partition coefficients between dimyristoyl lecithin and water. | Q52925493 | ||
| Permeability properties of phospholipid membranes: effect of cholesterol and temperature | Q52976794 | ||
| Quantitative comparison of the relative cell permeability of cyclic and linear peptides. | Q53545017 | ||
| Further Insights into the Effects of Pre-organizing the BimBH3 Helix | Q56983645 | ||
| Structure, dynamics and composition of the lipid-protein interface. Perspectives from spin-labelling | Q57363968 | ||
| A non-disruptive technique for loading calcium buffers and indicators into cells | Q59070146 | ||
| Enantiomer-Specific Bioactivities of Peptidomimetic Analogues of Mastoparan and Mitoparan: Characterization of Inverso Mastoparan as a Highly Efficient Cell Penetrating Peptide | Q60589686 | ||
| One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell | Q67390807 | ||
| Effects of tetanus toxin on catecholamine release from intact and digitonin-permeabilized chromaffin cells | Q68438737 | ||
| Lipid components of two different regions of an intestinal epithelial cell membrane of mouse | Q68700695 | ||
| Molecular structure and mechanisms of action of cyclic and linear ion transport antibiotics | Q70837268 | ||
| Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells | Q71157907 | ||
| Tumor cell killing enabled by listeriolysin O-liposome-mediated delivery of the protein toxin gelonin | Q73587471 | ||
| Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes | Q74448341 | ||
| Recent Advances in the High Resolution Structures of Bacterial Channels: Gramicidin A | Q74625144 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 29-53 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Methods in Molecular Biology | Q15752859 |
| P1476 | title | Getting across the cell membrane: an overview for small molecules, peptides, and proteins | |
| P478 | volume | 1266 |
| Q57157792 | "Fix and assay": separating in-cellulo sphingolipid reactions from analytical assay in time and space using an aldehyde-based fixative |
| Q92987552 | A Cyclic Pentamethinium Salt Induces Cancer Cell Cytotoxicity through Mitochondrial Disintegration and Metabolic Collapse |
| Q99367193 | A cytochrome c-chlorotoxin hybrid protein as a possible antiglioma drug |
| Q90167645 | Adduct formation of delamanid with NAD in mycobacteria |
| Q57785105 | An Investigation Into Rigidity-Activity Relationships in bisQAC Amphiphilic Antiseptics |
| Q90298646 | Barriers-on-chips: Measurement of barrier function of tissues in organs-on-chips |
| Q90098735 | Biological barriers, and the influence of protein binding on the passage of drugs across them |
| Q90041401 | Biophysical Insight on the Membrane Insertion of an Arginine-Rich Cell-Penetrating Peptide |
| Q92917314 | Biophysical approaches for exploring lipopeptide-lipid interactions |
| Q64065146 | Chemical Biology Gateways to Mapping Location, Association, and Pathway Responsivity |
| Q50070759 | Cytotoxic Evaluation of (2S)-5,7-Dihydroxy-6-prenylflavanone Derivatives Loaded PLGA Nanoparticles against MiaPaCa-2 Cells. |
| Q47708117 | Design and Application of Sensors for Chemical Cytometry |
| Q61444408 | Development of Highly Sensitive Biosensors of RAF Dimerization in Cells |
| Q98626229 | Development of peptide therapeutics: A nonclinical safety assessment perspective |
| Q89579792 | Effect of a newly synthesized quinoline-based compound (PPQ-8) on murine schistosomiasis mansoni |
| Q93061786 | Effect of small molecule signaling in PepFect14 transfection |
| Q64072589 | Evaluation of the Liver Toxicity of Extract via Triggering Necrosis |
| Q93110914 | Generation of a Small Library of Natural Products Designed to Cover Chemical Space Inexpensively |
| Q47324161 | Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)- |
| Q100446682 | High-throughput screening for high-efficiency small-molecule biosynthesis |
| Q60914066 | Identification of Small Peptides that Inhibit NADPH Oxidase (Nox2) Activation |
| Q96128046 | Identification of a potent and selective covalent Pin1 inhibitor |
| Q97883509 | Impact of Plasma Membrane Domains on IgG Fc Receptor Function |
| Q37017309 | Inforna 2.0: A Platform for the Sequence-Based Design of Small Molecules Targeting Structured RNAs |
| Q64892301 | Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area. |
| Q60342834 | Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts |
| Q48117422 | KCa(H2 O)2 [FeIII (CN)6 ]⋅H2 O Nanoparticles as Antimicrobial Agent against Staphylococcus aureus. |
| Q95301237 | LHRH-Conjugated Drugs as Targeted Therapeutic Agents for the Specific Targeting and Localized Treatment of Triple Negative Breast Cancer |
| Q93357911 | Luminescent nanomaterials for droplet tracking in a microfluidic trapping array |
| Q92287374 | Molecular Dynamics model of peptide-protein conjugation: case study of covalent complex between Sos1 peptide and N-terminal SH3 domain from Grb2 |
| Q95820132 | Molecular Mechanisms Underlying the Absorption of Aglycone and Glycosidic Flavonoids in a Caco-2 BBe1 Cell Model |
| Q58549114 | Novel small molecules affecting cell membrane as potential therapeutics for avian pathogenic Escherichia coli |
| Q60303017 | Peptide-nanoparticle conjugates: a next generation of diagnostic and therapeutic platforms? |
| Q89986113 | Physiological mechanisms determining eccrine sweat composition |
| Q90356764 | Placenta-on-a-Chip: In Vitro Study of Caffeine Transport across Placental Barrier Using Liquid Chromatography Mass Spectrometry |
| Q60935653 | Preferential Equilibrium Partitioning of Positively Charged Tryptophan into Phosphatidylcholine Bilayer Membranes |
| Q91794127 | Real-time monitoring of newly acidified organelles during autophagy enabled by reaction-based BODIPY dyes |
| Q92995125 | Role of Oxidized Lipids in Permeation of H2O2 Through a Lipid Membrane: Molecular Mechanism of an Inhibitor to Promoter Switch |
| Q36408938 | Role of cytoskeletal mechanics and cell membrane fluidity in the intracellular delivery of molecules mediated by laser-activated carbon nanoparticles. |
| Q64119166 | Root Exudation of Primary Metabolites: Mechanisms and Their Roles in Plant Responses to Environmental Stimuli |
| Q93381760 | Signalling and differentiation in emulsion-based multi-compartmentalized in vitro gene circuits |
| Q90069039 | Site-Directed Alkylation Detected by In-Gel Fluorescence (SDAF) to Determine the Topology Map and Probe the Solvent Accessibility of Membrane Proteins |
| Q49667930 | Solute carrier transporters: potential targets for digestive system neoplasms |
| Q47762139 | Spontaneous Membrane Translocating Peptides: The Role of Leucine-Arginine Consensus Motifs |
| Q50067679 | Supramolecular Assemblies for Transporting Proteins Across an Immiscible Solvent Interface |
| Q91526442 | Targeted enhancement of flotillin-dependent endocytosis augments cellular uptake and impact of cytotoxic drugs |
| Q47957753 | Targeting of a Helix-Loop-Helix Transcriptional Regulator by a Short Helical Peptide |
| Q91967477 | Tetrahydroindoles as Multipurpose Screening Compounds and Novel Sirtuin Inhibitors |
| Q49829267 | The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases |
| Q59126094 | The lipid mediator lysophosphatidic acid induces folding of disordered peptides with basic amphipathic character into rare conformations |
| Q58634365 | Variation of chemical constituents, antioxidant activity, and endogenous plant hormones throughout different ripening stages of highbush blueberry (Vaccinium corymbosum L.) cultivars produced in centre of Portugal |
| Q47104400 | Virtual Screening and Prediction of Binding of Caprine CSN1S2 Protein Tryptic Peptides to Glucokinase |
Search more.